Want to see CTNM full AI Analyst Report?
ETFs with Contineum Therapeutics, Inc. Class A (CTNM) Exposure
The following ETFs maintain exposure to Contineum Therapeutics, Inc. Class A (CTNM). ETF holdings data are updated periodically, based on the latest holdings the ETFs report, and are subject to change. To see a complete breakdown of any of the ETFs included in the table below, including asset class, AUM, and country allocations, click on the ticker symbol.
34 ETFs Hold Contineum Therapeutics, Inc. Class A (CTNM)
| Symbol | ETF Name | AUM | Expense Ratio | % Weight in ETF | Market Value | % Weight in CTNM |
|---|---|---|---|---|---|---|
| XPH | SPDR S&P Pharmaceuticals ETF | $466.58M | 0.35% | 0.45% | $2.04M | 0.66% |
| SBIO | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | 0.20% | $376.03K | 0.12% |
| IWC | iShares Micro-Cap ETF | $1.26B | 0.60% | 0.06% | $794.02K | 0.26% |
| VTWV | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | 0.03% | $346.06K | 0.08% |
| GSSC | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | $1.08B | 0.20% | 0.02% | $240.64K | 0.08% |
| OM3E | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | 0.02% | $278.60K | 0.09% |
| IBBQ | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | 0.02% | $23.96K | <0.01% |
| IBB | iShares Biotechnology ETF | $11.52B | 0.44% | 0.02% | $2.19M | 0.71% |
| IWN | iShares Russell 2000 Value ETF | $14.23B | 0.24% | 0.02% | $2.37M | 0.77% |
| AVSC | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | 0.02% | $517.08K | 0.17% |
| VRSD | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | 0.01% | $1,784.86 | <0.01% |
| VTWO | Vanguard Russell 2000 ETF | $17.04B | 0.06% | 0.01% | $2.19M | 0.49% |
| RTYS | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | <0.01% | $27.82K | <0.01% |
| RSSL | Global X Russell 2000 ETF | $1.47B | 0.08% | <0.01% | $126.91K | 0.04% |
| IWM | iShares Russell 2000 ETF | $76.76B | 0.19% | <0.01% | $6.54M | 2.13% |
| R2EH | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | <0.01% | $410.99K | 0.13% |
| ITWO | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | <0.01% | $14.78K | <0.01% |
| RB | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | <0.01% | $83.97 | <0.01% |
| SCHA | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | <0.01% | $1.49M | 0.49% |
| DFMC | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | <0.01% | $477.71K | 0.09% |
| VXF | Vanguard Extended Market ETF | $30.86B | 0.05% | <0.01% | $4.69M | 1.06% |
| DFAS | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | <0.01% | $996.02K | 0.32% |
| DXUV | Dimensional US Vector Equity ETF | $665.98M | 0.25% | <0.01% | $10.05K | <0.01% |
| HDG | ProShares Hedge Replication ETF | $22.40M | 0.95% | <0.01% | $317.22 | <0.01% |
| AVTM | Avantis Total Equity Markets ETF | $779.89M | 0.22% | <0.01% | $10.85K | <0.01% |
| DFSU | Dimensional US Sustainability Core 1 ETF | $2.41B | 0.15% | <0.01% | $26.06K | <0.01% |
| DCOR | Dimensional US Core Equity 1 ETF | $3.70B | 0.14% | <0.01% | $269.43K | 0.09% |
| VTI | Vanguard Total Stock Market ETF | $701.51B | 0.03% | <0.01% | $13.18M | 2.98% |
| SCHB | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | <0.01% | $234.42K | 0.08% |
| VTHR | Vanguard Russell 3000 ETF | $4.90B | 0.06% | <0.01% | $30.49K | <0.01% |
| DFAC | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | <0.01% | $398.43K | 0.13% |
| CAUS | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | <0.01% | $1,200.97 | <0.01% |
| DDGC | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | <0.01% | $2,920.29 | <0.01% |
| DDUM | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | <0.01% | $18.66 | <0.01% |
| Symbol | % Weight in ETF | ETF Name | AUM | Expense Ratio | Market Value | % Weight in CTNM |
|---|---|---|---|---|---|---|
| XPH | 0.45% | SPDR S&P Pharmaceuticals ETF | $466.58M | 0.35% | $2.04M | 0.66% |
| SBIO | 0.20% | ALPS Medical Breakthroughs ETF | $187.80M | 0.50% | $376.03K | 0.12% |
| IWC | 0.06% | iShares Micro-Cap ETF | $1.26B | 0.60% | $794.02K | 0.26% |
| VTWV | 0.03% | Vanguard Russell 2000 Value ETF | $1.31B | 0.06% | $346.06K | 0.08% |
| GSSC | 0.02% | Goldman Sachs Activebeta U.S. Small Cap Equity ETF | $1.08B | 0.20% | $240.64K | 0.08% |
| OM3E | 0.02% | iShares NASDAQ US Biotechnology UCITS ETF | $78.53M | 0.37% | $278.60K | 0.09% |
| IBBQ | 0.02% | Invesco Nasdaq Biotechnology ETF | $120.43M | 0.19% | $23.96K | <0.01% |
| IBB | 0.02% | iShares Biotechnology ETF | $11.52B | 0.44% | $2.19M | 0.71% |
| IWN | 0.02% | iShares Russell 2000 Value ETF | $14.23B | 0.24% | $2.37M | 0.77% |
| AVSC | 0.02% | Avantis U.S Small Cap Equity ETF | $3.23B | 0.25% | $517.08K | 0.17% |
| VRSD | 0.01% | Vanguard Russell 2000 U.S. Small-Cap UCITS ETF USD | $2.24M | ― | $1,784.86 | <0.01% |
| VTWO | 0.01% | Vanguard Russell 2000 ETF | $17.04B | 0.06% | $2.19M | 0.49% |
| RTYS | <0.01% | Invesco Russell 2000 UCITS ETF | $318.41M | 0.25% | $27.82K | <0.01% |
| RSSL | <0.01% | Global X Russell 2000 ETF | $1.47B | 0.08% | $126.91K | 0.04% |
| IWM | <0.01% | iShares Russell 2000 ETF | $76.76B | 0.19% | $6.54M | 2.13% |
| R2EH | <0.01% | State Street SPDR RUSSELL 2000 U.S. SMALL CAP UCITS ETF Accum Shs - Hedged EUR | $148.28M | 0.46% | $410.99K | 0.13% |
| ITWO | <0.01% | ProShares Russell 2000 High Income ETF | $182.44M | 0.55% | $14.78K | <0.01% |
| RB | <0.01% | ProShares Russell 2000 Dynamic Buffer ETF | $1.17M | 0.58% | $83.97 | <0.01% |
| SCHA | <0.01% | Schwab U.S. Small-Cap ETF | $22.39B | 0.03% | $1.49M | 0.49% |
| DFMC | <0.01% | U.S. Micro Cap Portfolio ETF | $211.48M | 0.41% | $477.71K | 0.09% |
| VXF | <0.01% | Vanguard Extended Market ETF | $30.86B | 0.05% | $4.69M | 1.06% |
| DFAS | <0.01% | Dimensional U.S. Small Cap ETF | $15.58B | 0.26% | $996.02K | 0.32% |
| DXUV | <0.01% | Dimensional US Vector Equity ETF | $665.98M | 0.25% | $10.05K | <0.01% |
| HDG | <0.01% | ProShares Hedge Replication ETF | $22.40M | 0.95% | $317.22 | <0.01% |
| AVTM | <0.01% | Avantis Total Equity Markets ETF | $779.89M | 0.22% | $10.85K | <0.01% |
| DFSU | <0.01% | Dimensional US Sustainability Core 1 ETF | $2.41B | 0.15% | $26.06K | <0.01% |
| DCOR | <0.01% | Dimensional US Core Equity 1 ETF | $3.70B | 0.14% | $269.43K | 0.09% |
| VTI | <0.01% | Vanguard Total Stock Market ETF | $701.51B | 0.03% | $13.18M | 2.98% |
| SCHB | <0.01% | Schwab U.S. Broad Market ETF | $45.06B | 0.03% | $234.42K | 0.08% |
| VTHR | <0.01% | Vanguard Russell 3000 ETF | $4.90B | 0.06% | $30.49K | <0.01% |
| DFAC | <0.01% | Dimensional U.S. Core Equity 2 ETF | $49.92B | 0.17% | $398.43K | 0.13% |
| CAUS | <0.01% | Avantis CIBC U.S. All-Cap Equity ETF Common Units Trust Units | $558.96M | ― | $1,200.97 | <0.01% |
| DDGC | <0.01% | Dimensional Funds ICAV - Global Core Equity UCITS ETF Accum USD | ― | 0.31% | $2,920.29 | <0.01% |
| DDUM | <0.01% | Dimensional Funds ICAV - Dimensional US Core Equity Market UCITS ETF USD Acc | ― | 0.16% | $18.66 | <0.01% |
Popular ETF Comparisons
CTNM ETF Exposure FAQ
What ETFs hold Contineum Therapeutics, Inc. Class A stock?
Contineum Therapeutics, Inc. Class A (CTNM) is currently held by 34 ETFs in TipRanks’ ETF exposure database. The ETF(s) with exposure to CTNM include iShares (IWN), iShares (IBB) and SPDR (XPH).
Which ETF has the largest exposure to CTNM?
The ETF with the largest exposure to CTNM is iShares (IWN), with approximately $2.37M in market value exposure.
How much CTNM stock is held by ETFs?
ETFs currently hold approximately $9.17M worth of Contineum Therapeutics, Inc. Class A (CTNM) stock, based on TipRanks’ ETF exposure data.
How often is ETF exposure data updated?
ETF exposure data is updated periodically based on the latest available ETF holdings and reporting data. Actual ETF positions may change between reporting periods.